» Articles » PMID: 25486041

Impact of Polymer Conformation on the Crystal Growth Inhibition of a Poorly Water-soluble Drug in Aqueous Solution

Overview
Journal Langmuir
Specialty Chemistry
Date 2014 Dec 9
PMID 25486041
Citations 10
Authors
Affiliations
Soon will be listed here.
Abstract

Poor aqueous solubility is a major hindrance to oral delivery of many emerging drugs. Supersaturated drug solutions can improve passive absorption across the gastrointestinal tract membrane as long as crystallization can be inhibited, enhancing the delivery of such poorly soluble therapeutics. Polymers can inhibit crystallization and prolong supersaturation; therefore, it is desirable to understand the attributes which render a polymer effective. In this study, the conformation of a polymer adsorbed to a crystal surface and its impact on crystal growth inhibition were investigated. The crystal growth rate of a poorly soluble pharmaceutical compound, felodipine, was measured in the presence of hydroxypropyl methylcellulose acetate succinate (HPMCAS) at two different pH conditions: pH 3 and pH 6.8. HPMCAS was found to be a less effective growth rate inhibitor at pH 3, below its pKa. It was expected that the ionization state of HPMCAS would most likely influence its conformation at the solid-liquid interface. Further investigation with atomic force microscopy (AFM) revealed significant differences in the conformation of HPMCAS adsorbed to felodipine at the two pH conditions. At pH 3, HPMCAS formed coiled globules on the surface, whereas at pH 6.8, HPMCAS adsorbed more uniformly. Thus, it appeared that the reduced effectiveness of HPMCAS at pH 3 was directly related to its conformation. The globule formation leaves many felodipine growth sites open and available for growth units to attach, rendering the polymer less effective as a growth rate inhibitor.

Citing Articles

Mucin Mimics and Impacts the Function of Polymeric Inhibitors in Stabilizing Drug Supersaturation.

Kordorwu V, Castleberry S, Lustig S, Carrier R Mol Pharm. 2025; 22(3):1396-1407.

PMID: 39977612 PMC: 11881134. DOI: 10.1021/acs.molpharmaceut.4c01102.


Implications of Low-concentration Polymer on the Physical Stability of Glassy Griseofulvin: Role of the Segmental Mobility.

Wang Y, Chin C, Shivashekaregowda N, Shi Q AAPS PharmSciTech. 2024; 25(5):103.

PMID: 38714634 DOI: 10.1208/s12249-024-02809-7.


Advances in the development of amorphous solid dispersions: The role of polymeric carriers.

Zhang J, Guo M, Luo M, Cai T Asian J Pharm Sci. 2023; 18(4):100834.

PMID: 37635801 PMC: 10450425. DOI: 10.1016/j.ajps.2023.100834.


Impact of Gastric pH Variations on the Release of Amorphous Solid Dispersion Formulations Containing a Weakly Basic Drug and Enteric Polymers.

Nguyen H, Van Duong T, Taylor L Mol Pharm. 2023; 20(3):1681-1695.

PMID: 36730186 PMC: 9997068. DOI: 10.1021/acs.molpharmaceut.2c00895.


Amorphous Solid Dispersions: Role of the Polymer and Its Importance in Physical Stability and In Vitro Performance.

Shi Q, Chen H, Wang Y, Wang R, Xu J, Zhang C Pharmaceutics. 2022; 14(8).

PMID: 36015373 PMC: 9413000. DOI: 10.3390/pharmaceutics14081747.


References
1.
Harrison A, Bilgili E, Beaudoin S, Taylor L . Atomic force microscope infrared spectroscopy of griseofulvin nanocrystals. Anal Chem. 2013; 85(23):11449-55. PMC: 3889117. DOI: 10.1021/ac4025889. View

2.
Raghavan S, Trividic A, Davis A, Hadgraft J . Crystallization of hydrocortisone acetate: influence of polymers. Int J Pharm. 2001; 212(2):213-21. DOI: 10.1016/s0378-5173(00)00610-4. View

3.
Takano R, Takata N, Saito R, Furumoto K, Higo S, Hayashi Y . Quantitative analysis of the effect of supersaturation on in vivo drug absorption. Mol Pharm. 2010; 7(5):1431-40. DOI: 10.1021/mp100109a. View

4.
Zimmermann A, Millqvist-Fureby A, Elema M, Hansen T, Mullertz A, Hovgaard L . Adsorption of pharmaceutical excipients onto microcrystals of siramesine hydrochloride: effects on physicochemical properties. Eur J Pharm Biopharm. 2008; 71(1):109-16. DOI: 10.1016/j.ejpb.2008.06.014. View

5.
Judge R, Johns M, WHITE E . Protein purification by bulk crystallization: the recovery of ovalbumin. Biotechnol Bioeng. 1995; 48(4):316-23. DOI: 10.1002/bit.260480404. View